Article

Cancer Drug Breakthroughs Highlight AJPB Week in Review

Author(s):

Davy James, Managing Editor

Top news of the week from The American Journal of Pharmacy Benefits.

Related Videos
Related Content
Red blood cells | Image Credit: © digitalpochi - stock.adobe.com
April 18th 2025

Momelotinib Shows Strong Efficacy in JAK-Exposed Myelofibrosis Patients

Alexandra Gerlach, Associate Editor
Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange
April 14th 2025

Antibody Drug Conjugates and Breast Cancer: Insights from a Pharmacy Times Peer Exchange

Alexandra Gerlach, Associate Editor
Concept image of an antibody drug conjugate | Image Credit: © AddMeshCube - stock.adobe.com
April 18th 2025

Real-World Data Show Improved Survival With Sacituzumab Govitecan as First-Line ADC in HER2-Low Breast Cancer

Alexandra Gerlach, Associate Editor
Pharmacy focus podcast
March 28th 2025

From Screening to Survival: The Pharmacist’s Role in Colorectal Cancer

Alexandra Gerlach, Associate Editor
Cancer cells in the blood stream | Image Credit: © freshidea - stock.adobe.com
April 17th 2025

Zanubrutinib Plus Venetoclax and Obinutuzumab Yields Deep Remissions in Patients With Chronic Lymphocytic Leukemia

Alexandra Gerlach, Associate Editor
TKI binding to breast cancer cells | This image is AI generated
April 17th 2025

Tucatinib and Trastuzumab Demonstrates Safety, Efficacy in HER2-Mutated Breast Cancer

Alexandra Gerlach, Associate Editor